Physician profile
Evan Dunn
NPI 1639625924
$3,835.56
in general payments reported to CMS, 2019-2025
17 companies · $859 in 2025
The $859 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $333 · 2021: $363 · 2022: $527 · 2023: $644 · 2024: $457 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,474.71 | 2019-2025 | Precision7, Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $550.32 | 2022-2025 | Infuse, Miebo, Xiidra |
| Oyster Point Pharma, INC. | $315.73 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $201.39 | 2020-2025 | Idosetr, Istent Infinite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $188.05 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $184.28 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $159.16 | 2019-2023 | |
| Harrow Eye, LLC | $135.79 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $129.80 | 2021-2024 | Cequa |
| Abb Con-Cise Optical Group LLC | $114.85 | 2019-2020 | |
| Optos, INC. | $111.72 | 2019-2020 | |
| Shire North American Group INC | $85.34 | 2019 | |
| Dompe US, INC. | $57.21 | 2025 | Oxervate |
| Coopervision INC. | $50.98 | 2019-2021 | |
| Allergan, INC. | $33.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.16 | 2023 | Vuity |
| Eyevance Pharmaceuticals LLC | $17.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.